GLP-1 Drugs: A Potential Game-Changer for RA, Psoriasis and PsA Recent studies have unveiled exciting potential for GLP-1 drugs like Ozempic, Mounjaro, and Zepbound in treating autoimmune conditions such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis
doi: 10.1038/s41580-019-0101-y 111 HolleyA
Notably, GLP-1(936) increased dissociation of the inhibitory GTP-binding protein G oA (Fig
Acceptance of insurance and offering full prior authorization support is another crucial aspect
Spoiler: Its not just stubborn skinits hormones, inflammation, and more
Integrating new evidence into clinical practice ensures that patients benefit from the most recent advancements in diabetes treatment, improving outcomes and quality of life